Norges Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $112M | Buy |
+2,043,879
| New | +$112M | 0.01% | 660 |
|
2025
Q1 | – | Sell |
-3,569,831
| Closed | -$235M | – | 241 |
|
2024
Q4 | $235M | Buy |
+3,569,831
| New | +$235M | 0.03% | 428 |
|
2024
Q3 | – | Sell |
-3,619,503
| Closed | -$298M | – | 244 |
|
2024
Q2 | $298M | Buy |
3,619,503
+140,991
| +4% | +$11.6M | 0.04% | 349 |
|
2024
Q1 | $304M | Buy |
3,478,512
+117,202
| +3% | +$10.2M | 0.05% | 336 |
|
2023
Q4 | $324M | Buy |
3,361,310
+318,010
| +10% | +$30.7M | 0.06% | 299 |
|
2023
Q3 | $269M | Buy |
3,043,300
+6,801
| +0.2% | +$602K | 0.05% | 311 |
|
2023
Q2 | $263M | Buy |
3,036,499
+152,016
| +5% | +$13.2M | 0.05% | 324 |
|
2023
Q1 | $280M | Buy |
2,884,483
+130,466
| +5% | +$12.7M | 0.06% | 292 |
|
2022
Q4 | $285M | Buy |
2,754,017
+157,654
| +6% | +$16.3M | 0.07% | 275 |
|
2022
Q3 | $220M | Buy |
2,596,363
+32,727
| +1% | +$2.77M | 0.06% | 309 |
|
2022
Q2 | $212M | Buy |
2,563,636
+5,338
| +0.2% | +$442K | 0.05% | 316 |
|
2022
Q1 | $197M | Buy |
2,558,298
+208,758
| +9% | +$16.1M | 0.04% | 388 |
|
2021
Q4 | $208M | Buy |
2,349,540
+223,693
| +11% | +$19.8M | 0.04% | 396 |
|
2021
Q3 | $164M | Sell |
2,125,847
-42,198
| -2% | -$3.26M | 0.04% | 460 |
|
2021
Q2 | $181M | Sell |
2,168,045
-26,274
| -1% | -$2.19M | 0.04% | 443 |
|
2021
Q1 | $166M | Buy |
2,194,319
+744,823
| +51% | +$56.2M | 0.04% | 446 |
|
2020
Q4 | $127M | Buy |
1,449,496
+32,054
| +2% | +$2.81M | 0.03% | 513 |
|
2020
Q3 | $108M | Sell |
1,417,442
-60,415
| -4% | -$4.6M | 0.03% | 512 |
|
2020
Q2 | $182M | Sell |
1,477,857
-75,441
| -5% | -$9.3M | 0.05% | 322 |
|
2020
Q1 | $131M | Sell |
1,553,298
-199,543
| -11% | -$16.9M | 0.05% | 352 |
|
2019
Q4 | $148M | Buy |
1,752,841
+245,138
| +16% | +$20.7M | 0.04% | 402 |
|
2019
Q3 | $102M | Sell |
1,507,703
-229,622
| -13% | -$15.5M | 0.03% | 505 |
|
2019
Q2 | $149M | Buy |
1,737,325
+256,507
| +17% | +$22M | 0.05% | 377 |
|
2019
Q1 | $132M | Buy |
1,480,818
+293,094
| +25% | +$26M | 0.04% | 401 |
|
2018
Q4 | $101M | Buy |
1,187,724
+117,982
| +11% | +$10M | 0.04% | 437 |
|
2018
Q3 | $104M | Buy |
1,069,742
+109,408
| +11% | +$10.6M | 0.03% | 485 |
|
2018
Q2 | $90.5M | Buy |
960,334
+44,480
| +5% | +$4.19M | 0.03% | 523 |
|
2018
Q1 | $74.2M | Buy |
915,854
+37,798
| +4% | +$3.06M | 0.03% | 594 |
|
2017
Q4 | $78.3M | Buy |
878,056
+136,767
| +18% | +$12.2M | 0.03% | 570 |
|
2017
Q3 | $69M | Hold |
741,289
| – | – | 0.03% | 606 |
|
2017
Q2 | $67.3M | Sell |
741,289
-195,124
| -21% | -$17.7M | 0.03% | 596 |
|
2017
Q1 | $82.2M | Sell |
936,413
-77,013
| -8% | -$6.76M | 0.03% | 489 |
|
2016
Q4 | $84M | Buy |
1,013,426
+26,046
| +3% | +$2.16M | 0.04% | 476 |
|
2016
Q3 | $87.3M | Buy |
987,380
+36,542
| +4% | +$3.23M | 0.04% | 438 |
|
2016
Q2 | $74M | Sell |
950,838
-159,423
| -14% | -$12.4M | 0.04% | 486 |
|
2016
Q1 | $91.6M | Sell |
1,110,261
-57,295
| -5% | -$4.73M | 0.05% | 389 |
|
2015
Q4 | $122M | Sell |
1,167,556
-9,470
| -0.8% | -$992K | 0.06% | 291 |
|
2015
Q3 | $124M | Buy |
1,177,026
+174,011
| +17% | +$18.3M | 0.07% | 297 |
|
2015
Q2 | $137M | Buy |
1,003,015
+40,944
| +4% | +$5.6M | 0.07% | 281 |
|
2015
Q1 | $120M | Sell |
962,071
-82,532
| -8% | -$10.3M | 0.06% | 320 |
|
2014
Q4 | $94.4M | Sell |
1,044,603
-72,230
| -6% | -$6.53M | 0.05% | 366 |
|
2014
Q3 | $80.6M | Sell |
1,116,833
-1,116,833
| -50% | -$80.6M | 0.04% | 409 |
|
2014
Q2 | $139M | Buy |
2,233,666
+1,116,833
| +100% | +$69.5M | 0.04% | 468 |
|
2014
Q1 | $76.2M | Sell |
1,116,833
-62,275
| -5% | -$4.25M | 0.04% | 403 |
|
2013
Q4 | $82.9M | Sell |
1,179,108
-367,869
| -24% | -$25.9M | 0.05% | 362 |
|
2013
Q3 | $112M | Buy |
1,546,977
+949,969
| +159% | +$68.6M | 0.07% | 296 |
|
2013
Q2 | $33.3M | Buy |
+597,008
| New | +$33.3M | 0.02% | 722 |
|